9th Annual microRNA: Targets and Tools for Therapeutic Development
March 4-5, 2013
Boston Marriott Cambridge
microRNAs are playing an important role in a range of diseases such as cancer, metabolic diseases and cardiovascular disorders. Their involvement in many physiological pathways, makes them an excellent target for pharmaceutical drug development and their use as biomarkers or for profiling and screening turns them into a valuable tool for diagnostics.
Join your peers for a program on the latest developments in using miRNA’s for health and disease, the novel applications and progress made in manipulating microRNA, and the opportunities for using microRNA as a tool.
The program features a world-class speaker lineup, including representatives from Hoffman-La Roche. Novartis, SomaGenics and Yale School of Medicine. Topics to be covered include:
- miRNA as a diagnostic tool
- miRNA targets for drug development
- miRNA identification and profiling approaches
- miRNA as biomarker
- miRNA as cancer therapeutics
- microRNA in the clinic
- Blood-based assays
- Novel microRNA inhibitors
Find the full agenda, speaker list and event updates at http://www.healthtech.com/mrn.
Secure your place early to save.